Avanos Medical (NYSE:AVNS) Releases Quarterly Earnings Results, Beats Expectations By $0.03 EPS

Avanos Medical (NYSE:AVNS) released its quarterly earnings results on Wednesday. The company reported $0.43 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.03, Zacks reports. Avanos Medical had a net margin of 2.30% and a return on equity of 4.70%. Avanos Medical updated its FY 2025 guidance to 1.050-1.250 EPS.

Avanos Medical Stock Up 2.9 %

Shares of AVNS stock traded up $0.45 during trading hours on Wednesday, hitting $16.01. 407,496 shares of the company’s stock traded hands, compared to its average volume of 535,439. The stock’s fifty day simple moving average is $16.15 and its two-hundred day simple moving average is $19.73. The company has a quick ratio of 1.46, a current ratio of 2.22 and a debt-to-equity ratio of 0.12. The stock has a market cap of $735.96 million, a price-to-earnings ratio of 47.54 and a beta of 0.98. Avanos Medical has a 12-month low of $14.40 and a 12-month high of $25.36.

Analyst Upgrades and Downgrades

Separately, StockNews.com lowered Avanos Medical from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.